Discussion
This review has compiled and summarized the existing observational studies related to COVID-19 in the pediatric population. The global incidence of COVID-19 cases has been on the rise. According to the largest epidemiological survey, the majority of these patients fall within the age range of 30 to 79 years, comprising 87% of cases. It is noteworthy that older individuals and those with pre-existing medical conditions are more susceptible to the adverse effects of the virus. In contrast, the number of cases among children is relatively low. Patients under the age of 19 accounted for just 2.2% of the 44,672 confirmed cases (Wu Z et al., 2020), with only one recorded death. This translates to an exceptionally low crude mortality rate of 0.1%, which stands in stark contrast to the higher rates reported in current published data for adults, ranging from 2.3% to 14.6% ( Chen N et al., 2020,; Huang C et al., 2020; Wang D et al.;2020).